None listed
Conditions
Interventions
None listed
Sponsors
Bayer Korea
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adult (Age > 18) female and male patients diagnosed with acute ischemic stroke patients admitted to the participating centers within 7 days after onset (the time of first recognition of stroke symptoms) 2. Patients who were diagnosed for any type of AF by history or documented during hospitalization 3. Relevant ischemic lesions documented on diffusion-weighted imaging (DWI)
Exclusion criteria
Exclusion criteria: Patients who refused to participate in this study or to give an informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence rate of a composite event of recurrent stroke, myocardial infarction, and all kinds of death | — |
Secondary
| Measure | Time frame |
|---|---|
| incidence rate of a composite event of recurrent stroke, myocardial infarction, and vascular death;Stroke recurrence;Stroke recurrence;Myocardial infarction or hospitalization for unstable angina or coronary revascularization;All kinds of death;Any invasive procedures considering temporary suspention of antithrombotic medication;Major bleeding;Symptomatic hemorrhagic transformation of the primary ischemic lesion | — |
Countries
Korea, Republic of
Contacts
Public ContactKeon-Joo Lee
Seoul National University Bundang Hospital
Outcome results
None listed